Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment

Basic Research in Cardiology

Volumn 94, Issue 1, 1999, Pages 49-59

  Choudhury, L ^a   Elliott, P ^b   Rimoldi, O ^a   Ryan, M ^a   Lammertsma, A A ^a   Boyd, H ^a   McKenna, W J ^b   Camici, P G ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Calcium channel blockers; Hypertrophic cardiomyopathy; Positron emission tomography; Transmural blood flow

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIPYRIDAMOLE; OXYGEN 15; VERAPAMIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART MUSCLE BLOOD FLOW; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; POSITRON EMISSION TOMOGRAPHY; SYMPTOM;

ADULT; CALCIUM CHANNEL BLOCKERS; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY VESSELS; DIPYRIDAMOLE; FEMALE; HUMANS; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; TOMOGRAPHY, EMISSION-COMPUTED; VASODILATOR AGENTS; VERAPAMIL;

EID: 0032934530     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003950050126     Document Type: Article

References (25)

1. Araujo LI, Lammertsma AA, Rhodes CG et al. (1991) Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15 labelled carbon dioxide inhalation and positron emission tomography. Circulation 83: 875-885
2. Bonow RO, Dilsizian V, Rosing DR, Maron BJ, Bacharach SL, Green MV (1985) Verapamil-induced improvement in left ventricular diastolic rilling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. Circulation 72: 853-864
3. Bonow RO, Vitale DF, Maron BJ, Bacharach SL, Frederick TM, Green MV (1987) Regional left ventricular asynchrony and impaired global left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil. J Am Coll Cardiol 9: 1108-16
4. Camici PG, Chiriatti G, Lorenzoni R, Bellina RC, Gistri R, Italiani G, Parodi O, Salvadori PA, Nista N, Papi L, L'Abbate A (1991) Coronary vasodilatation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with positron emission tomography. J Am Coll Cardiol 17: 879-886
5. Camici PG (1997) Microcirculation: what is the role of calcium antagonists? Eur Heart J 18 (Supplement A): A51-A55
6. Cannon III RO, Dilsizian V, O'Gara PT, Udelson JE, Schenke WH, Quyyumi A, Fananapazir L, Bonow RO (1991) Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible Thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation 83: 1660-1667
7. Czernin J Porenta G, Brunken R, Krivokapich J, Chen K (1993) Regional blood flow, oxidative metabolism and glucose utilization in patients with recent myocardial infarction. Circulation 88: 884-95
8. Elliott PM, Rosano GMC, Gill J, Kaski JC, Poole-Wilson PA, McKenna WJ (1996) Coronary sinus pH during dipyridamole infusion in patients with angina and hypertrophic cardiomyopathy. Heart 75: 179-83
9. Frank S, Braunwald E (1968) Idiopathic hypertrophic subaortic stenosis; clinical analysis of 126 patients with emphasis on the natural history. Circulation 37: 759-88
10. Gistri R, Cecchi F, Choudhury L, Montereggi A, Sorace O, Salvadori PA, Camici PG (1994) Effect of verapamil treatment on absolute myocardial blood flow in hypertrophic cardiomyopathy. Am J Cardiol 74: 363-8
11. Hoffman EJ, Huang SC, Phelps ME (1979) Quantitation in positron emission tomography: 1. effect of object size. J Comput Assist Tomogr 3: 299-308
12. Hoffman JI (1987) Transmural myocardial perfusion. Progress in Cardiovascular Diseases XXIX: 429-464
13. Iida H, Rhodes CG, de Silva R, Yamamoto Y, Araujo LI, Maseri A, Jones T (1991) Myocardial tissue fraction: correction for partial volume effects and measure of of tissue viability. J Nucl Med 32: 2169-217
14. Kaltembach M, Hopf R (1985) Treatment of hypertrophic cardiomyopathy relation to pathological mechanisms. J Mol Cell Cardiol 17 (supp II): 59-68
15. Maron BJ, Gottdiener JS, Epstein SE (1981) Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 48: 418-28
16. Maron BJ, Wolfson JK, Epstein SE, Roberts WC (1986) Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8: 545-557
17. O'Gorman DJ, Sheridan DJ (1991) Abnormalities of the coronary circulation associated with left ventricular hypertrophy. Clin Sci 81: 703-13
18. Parodi O, Schelbert HR, Schwaiger M, Hansen H, Selin C, Hoffman EJ (1984) Cardiac emission computed tomography: Underestimation of regional tracer concentration due to wall motion abnormalities. J Comput Assist Tomogr 8: 1083-92
19. Parodi O, Neglia D, Palombo C, Sambuceti G, Giorgetti A, Marabotti C, Galoppin M, Simonetti I, L'Abbate A (1997) Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension. Circulation 96: 864-873
20. Pasternac A, Noble J, Streulens Y, Elie R, Henschke C, Bourassa MG (1982) Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteriograms. Circulation 65: 778-89
21. Robb RA (19??) A software system for interactive and quantitative analysis of biomedical images. In: Hohne, Fuchs KH, Pizer SM (eds) 3D Imaging in Medicine, NATO ASI, vol F60: 333-361
22. Rossen JD, Winniford MD (1993) Effects of increases in heart rate and arterial pressure on coronary flow reserve in humans. J Am Coll Cardiol 21: 343-348
23. Scheler S, Motz W, Strauer BE (1992) Transient myocardial ischaemia in hypertensives: the missing link with left ventricular hypertrophy. Eur Heart J 13 (suppl D): 62-65
24. Spinks TJ, Jones T, Gilardi MC, Heather JD (1988) Physical performance of the latest generation of commercial positron scanners. IEEE Trans Nucl Sci NS-35: 721-725
25. Udelson JE, Bonow RO, O'Gara PT, Maron BJ, Van Lingen A, Bacharach SL, Epstein SE (1989) Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 79: 1052-1060